 | • レポートコード：MRC2012A3013 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、中枢神経系治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。中枢神経系治療薬の種類別市場規模（OTC、処方薬）、用途別市場規模（病院、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Biogen、Merck、Novartis、Pfizer、Otsuka、Teva、Novartis、EliLilly、Johnson & Johnson、AstraZeneca、Takeda、 ・地域別グローバル市場分析 2015年-2020年 ・中枢神経系治療薬の北米市場（アメリカ、カナダ、メキシコ） ・中枢神経系治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・中枢神経系治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・中枢神経系治療薬の南米市場（ブラジル、アルゼンチン） ・中枢神経系治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：OTC、処方薬 ・用途別分析：病院、小売薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Drugs for Central Nervous System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Drugs for Central Nervous System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drugs for Central Nervous System market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drugs for Central Nervous System market has been segmented into
OTC
Rx Drugs
By Application, Drugs for Central Nervous System has been segmented into:
Hospital
Retail Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Central Nervous System market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Central Nervous System markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Central Nervous System market.
The report offers in-depth assessment of the growth and other aspects of the Drugs for Central Nervous System market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Drugs for Central Nervous System Market Share Analysis
Drugs for Central Nervous System competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Central Nervous System sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Central Nervous System sales, revenue and market share for each player covered in this report.
The major players covered in Drugs for Central Nervous System are:
Biogen
Merck
Novartis
Pfizer
Otsuka
Teva
Novartis
EliLilly
Johnson & Johnson
AstraZeneca
Takeda
Among other players domestic and global, Drugs for Central Nervous System market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Central Nervous System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Central Nervous System, with price, sales, revenue and global market share of Drugs for Central Nervous System in 2018 and 2019.
Chapter 3, the Drugs for Central Nervous System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Central Nervous System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drugs for Central Nervous System market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drugs for Central Nervous System sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Drugs for Central Nervous System Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Central Nervous System Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Central Nervous System Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Overview of Global Drugs for Central Nervous System Market
1.4.1 Global Drugs for Central Nervous System Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biogen SWOT Analysis
2.1.4 Biogen Product and Services
2.1.5 Biogen Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Otsuka
2.5.1 Otsuka Details
2.5.2 Otsuka Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Otsuka SWOT Analysis
2.5.4 Otsuka Product and Services
2.5.5 Otsuka Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva SWOT Analysis
2.6.4 Teva Product and Services
2.6.5 Teva Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 EliLilly
2.8.1 EliLilly Details
2.8.2 EliLilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 EliLilly SWOT Analysis
2.8.4 EliLilly Product and Services
2.8.5 EliLilly Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 AstraZeneca SWOT Analysis
2.10.4 AstraZeneca Product and Services
2.10.5 AstraZeneca Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Takeda
2.11.1 Takeda Details
2.11.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Takeda SWOT Analysis
2.11.4 Takeda Product and Services
2.11.5 Takeda Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drugs for Central Nervous System Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drugs for Central Nervous System Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Central Nervous System Manufacturer Market Share in 2019
3.3.2 Top 6 Drugs for Central Nervous System Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drugs for Central Nervous System Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Central Nervous System Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drugs for Central Nervous System Revenue and Market Share by Regions (2015-2020)
4.2 North America Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
4.3 Europe Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
4.5 South America Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drugs for Central Nervous System Sales, Revenue and Market Share by Country
5.1.1 North America Drugs for Central Nervous System Sales and Market Share by Country (2015-2020)
5.1.2 North America Drugs for Central Nervous System Revenue and Market Share by Country (2015-2020)
5.2 United States Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
5.3 Canada Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
5.4 Mexico Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drugs for Central Nervous System Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs for Central Nervous System Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drugs for Central Nervous System Revenue and Market Share by Country (2015-2020)
6.2 Germany Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
6.3 UK Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
6.4 France Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
6.5 Russia Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
6.6 Italy Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drugs for Central Nervous System Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drugs for Central Nervous System Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drugs for Central Nervous System Revenue and Market Share by Regions (2015-2020)
7.2 China Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
7.3 Japan Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
7.4 Korea Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
7.5 India Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
7.7 Australia Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drugs for Central Nervous System Sales, Revenue and Market Share by Country
8.1.1 South America Drugs for Central Nervous System Sales and Market Share by Country (2015-2020)
8.1.2 South America Drugs for Central Nervous System Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
8.3 Argentina Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Drugs for Central Nervous System Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Drugs for Central Nervous System Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Drugs for Central Nervous System Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
9.3 Turkey Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
9.4 Egypt Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
9.5 South Africa Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drugs for Central Nervous System Sales and Market Share by Type (2015-2020)
10.2 Global Drugs for Central Nervous System Revenue and Market Share by Type (2015-2020)
10.3 Global Drugs for Central Nervous System Price by Type (2015-2020)
11 Global Drugs for Central Nervous System Market Segment by Application
11.1 Global Drugs for Central Nervous System Sales Market Share by Application (2015-2020)
11.2 Global Drugs for Central Nervous System Revenue Market Share by Application (2015-2020)
11.3 Global Drugs for Central Nervous System Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drugs for Central Nervous System Sales, Revenue and Growth Rate (2021-2025)
12.2 Drugs for Central Nervous System Market Forecast by Regions (2021-2025)
12.2.1 North America Drugs for Central Nervous System Market Forecast (2021-2025)
12.2.2 Europe Drugs for Central Nervous System Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drugs for Central Nervous System Market Forecast (2021-2025)
12.2.4 South America Drugs for Central Nervous System Market Forecast (2021-2025)
12.2.5 Middle East & Africa Drugs for Central Nervous System Market Forecast (2021-2025)
12.3 Drugs for Central Nervous System Market Forecast by Type (2021-2025)
12.3.1 Global Drugs for Central Nervous System Sales Forecast by Type (2021-2025)
12.3.2 Global Drugs for Central Nervous System Market Share Forecast by Type (2021-2025)
12.4 Drugs for Central Nervous System Market Forecast by Application (2021-2025)
12.4.1 Global Drugs for Central Nervous System Sales Forecast by Application (2021-2025)
12.4.2 Global Drugs for Central Nervous System Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Drugs for Central Nervous System Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Central Nervous System by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Central Nervous System Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Biogen Basic Information, Manufacturing Base and Competitors
Table 8. Biogen Drugs for Central Nervous System Major Business
Table 9. Biogen Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 10. Biogen SWOT Analysis
Table 11. Biogen Drugs for Central Nervous System Product and Services
Table 12. Biogen Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Drugs for Central Nervous System Major Business
Table 15. Merck Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 16. Merck SWOT Analysis
Table 17. Merck Drugs for Central Nervous System Product and Services
Table 18. Merck Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Drugs for Central Nervous System Major Business
Table 21. Novartis Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Drugs for Central Nervous System Product and Services
Table 24. Novartis Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Drugs for Central Nervous System Major Business
Table 27. Pfizer Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Drugs for Central Nervous System Product and Services
Table 30. Pfizer Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Otsuka Basic Information, Manufacturing Base and Competitors
Table 32. Otsuka Drugs for Central Nervous System Major Business
Table 33. Otsuka Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 34. Otsuka SWOT Analysis
Table 35. Otsuka Drugs for Central Nervous System Product and Services
Table 36. Otsuka Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Basic Information, Manufacturing Base and Competitors
Table 38. Teva Drugs for Central Nervous System Major Business
Table 39. Teva Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 40. Teva SWOT Analysis
Table 41. Teva Drugs for Central Nervous System Product and Services
Table 42. Teva Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Drugs for Central Nervous System Major Business
Table 45. Novartis Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 46. Novartis SWOT Analysis
Table 47. Novartis Drugs for Central Nervous System Product and Services
Table 48. Novartis Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. EliLilly Basic Information, Manufacturing Base and Competitors
Table 50. EliLilly Drugs for Central Nervous System Major Business
Table 51. EliLilly Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 52. EliLilly SWOT Analysis
Table 53. EliLilly Drugs for Central Nervous System Product and Services
Table 54. EliLilly Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 56. Johnson & Johnson Drugs for Central Nervous System Major Business
Table 57. Johnson & Johnson Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 58. Johnson & Johnson SWOT Analysis
Table 59. Johnson & Johnson Drugs for Central Nervous System Product and Services
Table 60. Johnson & Johnson Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Drugs for Central Nervous System Major Business
Table 63. AstraZeneca Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 64. AstraZeneca SWOT Analysis
Table 65. AstraZeneca Drugs for Central Nervous System Product and Services
Table 66. AstraZeneca Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Takeda Basic Information, Manufacturing Base and Competitors
Table 68. Takeda Drugs for Central Nervous System Major Business
Table 69. Takeda Drugs for Central Nervous System Total Revenue (USD Million) (2017-2018)
Table 70. Takeda SWOT Analysis
Table 71. Takeda Drugs for Central Nervous System Product and Services
Table 72. Takeda Drugs for Central Nervous System Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Drugs for Central Nervous System Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Drugs for Central Nervous System Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Drugs for Central Nervous System Sales by Regions (2015-2020) (K Units)
Table 76. Global Drugs for Central Nervous System Sales Market Share by Regions (2015-2020)
Table 77. Global Drugs for Central Nervous System Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Drugs for Central Nervous System Sales by Countries (2015-2020) (K Units)
Table 79. North America Drugs for Central Nervous System Sales Market Share by Countries (2015-2020)
Table 80. North America Drugs for Central Nervous System Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Drugs for Central Nervous System Revenue Market Share by Countries (2015-2020)
Table 82. Europe Drugs for Central Nervous System Sales by Countries (2015-2020) (K Units)
Table 83. Europe Drugs for Central Nervous System Sales Market Share by Countries (2015-2020)
Table 84. Europe Drugs for Central Nervous System Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Drugs for Central Nervous System Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Drugs for Central Nervous System Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Drugs for Central Nervous System Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Drugs for Central Nervous System Sales by Countries (2015-2020) (K Units)
Table 89. South America Drugs for Central Nervous System Sales Market Share by Countries (2015-2020)
Table 90. South America Drugs for Central Nervous System Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Drugs for Central Nervous System Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Drugs for Central Nervous System Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Drugs for Central Nervous System Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Drugs for Central Nervous System Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Drugs for Central Nervous System Revenue Market Share by Countries (2015-2020)
Table 96. Global Drugs for Central Nervous System Sales by Type (2015-2020) (K Units)
Table 97. Global Drugs for Central Nervous System Sales Share by Type (2015-2020)
Table 98. Global Drugs for Central Nervous System Revenue by Type (2015-2020) (USD Million)
Table 99. Global Drugs for Central Nervous System Revenue Share by Type (2015-2020)
Table 100. Global Drugs for Central Nervous System Sales by Application (2015-2020) (K Units)
Table 101. Global Drugs for Central Nervous System Sales Share by Application (2015-2020)
Table 102. Global Drugs for Central Nervous System Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Drugs for Central Nervous System Market Share Forecast by Regions (2021-2025)
Table 104. Global Drugs for Central Nervous System Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Drugs for Central Nervous System Market Share Forecast by Type (2021-2025)
Table 106. Global Drugs for Central Nervous System Sales Forecast by Application (2021-2025)
Table 107. Global Drugs for Central Nervous System Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drugs for Central Nervous System Picture
Figure 2. Global Sales Market Share of Drugs for Central Nervous System by Type in 2019
Figure 3. OTC Picture
Figure 4. Rx Drugs Picture
Figure 5. Drugs for Central Nervous System Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Retail Pharmacy Picture
Figure 8. Global Drugs for Central Nervous System Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Drugs for Central Nervous System Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Drugs for Central Nervous System Sales Market Share by Manufacturer in 2019
Figure 29. Global Drugs for Central Nervous System Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Drugs for Central Nervous System Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Drugs for Central Nervous System Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Drugs for Central Nervous System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Drugs for Central Nervous System Revenue Market Share by Regions (2015-2020)
Figure 36. Global Drugs for Central Nervous System Revenue Market Share by Regions in 2018
Figure 37. North America Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
Figure 38. Europe Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
Figure 40. South America Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Drugs for Central Nervous System Sales and Growth Rate (2015-2020)
Figure 42. North America Drugs for Central Nervous System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Drugs for Central Nervous System Sales Market Share by Countries (2015-2020)
Figure 44. North America Drugs for Central Nervous System Sales Market Share by Countries in 2018
Figure 45. North America Drugs for Central Nervous System Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Drugs for Central Nervous System Revenue Market Share by Countries in 2018
Figure 47. United States Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Drugs for Central Nervous System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Drugs for Central Nervous System Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Drugs for Central Nervous System Revenue Market Share by Countries in 2019
Figure 53. Germany Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Drugs for Central Nervous System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Drugs for Central Nervous System Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Drugs for Central Nervous System Revenue Market Share by Regions 2019
Figure 61. China Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Drugs for Central Nervous System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Drugs for Central Nervous System Sales Market Share by Countries in 2019
Figure 68. South America Drugs for Central Nervous System Revenue Market Share by Countries in 2019
Figure 69. Brazil Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Drugs for Central Nervous System Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Drugs for Central Nervous System Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Drugs for Central Nervous System Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Drugs for Central Nervous System Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Drugs for Central Nervous System Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Drugs for Central Nervous System Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Drugs for Central Nervous System Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Drugs for Central Nervous System Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Drugs for Central Nervous System Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Drugs for Central Nervous System Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Drugs for Central Nervous System Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Drugs for Central Nervous System Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
中枢神経系疾患治療薬の世界市場（～2026年） A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous system Market Analysis and Insights: Global Drugs for Central Nervous System Diseases Market The global Drugs for Central Nervous System Diseases market size is projected to reac…- 中枢神経系疾患治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Drugs for Central Nervous System Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…
- 中枢神経系（CNS）治療の世界市場（～2026年） A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders. Advancements in diagnostics, therapeutics and drug discovery techniques will further trigger the growth of central nervous system therapeutic market. Market Ana…
- MSDドラッグの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global MSD Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The MSD Drugs market report provides a …
- インターフェロンベータ-1b治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Interferon Beta-1b Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…